Sharemaestro Newsreel

Stryker Corporation $SYK Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB reduced its stake in Stryker Corporation (NYSE:SYK) by 1.1% in the second quarter of 2026, selling 3,128 shares but retaining a substantial holding valued at approximately $90.4 million. Despite this sale, institutional investors and hedge funds collectively own a significant 77.09% …

AdaptHealth (AHCO) Q2 2026 Earnings Call Transcript

Bruker (BRKR) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Director of Investor Relations - Joe KostkaPresident and Chief Executive Officer - Frank LaukienExecutive Vice President and Chief Financial Officer - Gerald Herman TAKEAWAYS Revenue -- $838.5 million …

Neuronetics outlines 2026 revenue of $160M-$164M while shifting NeuroStar to broader ownership models

Earnings Call Insights: Neuronetics (STIM) Q2 2026 MANAGEMENT VIEW * "I'm pleased to report the second quarter began to reflect our steady execution against the goals I cited last quarter. Total revenue was $41.6 million, up approximately 9% versus the second quarter of last …

Price-Driven Insight from (LIVN) for Rule-Based Strategy

This article provides a price-driven insight into Livanova Plc (NASDAQ: LIVN) for rule-based trading strategies. It highlights weak near-term sentiment challenging long-term strength, with support being tested. The analysis identifies an exceptional 28.8:1 risk-reward setup targeting an 8.4% gain against 0.3% risk, and outlines …

Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT artificially inflated its reported U.S. handpiece …

TD Cowen Issues Pessimistic Forecast for Quanterix (NASDAQ:QTRX) Stock Price

TD Cowen has lowered its price target for Quanterix (NASDAQ:QTRX) from $4.00 to $3.00, maintaining a "hold" rating due to the company's recent earnings and revenue misses. The stock, currently trading near its 52-week low at $2.48, holds an average analyst rating of "Reduce" …

Axogen (AXGN) Is Up 5.4% After Raising 2026 Revenue Outlook Despite Ongoing Losses – Has The Bull Case Changed?

Axogen (AXGN) reported higher Q2 2026 revenue of US$69.73 million but increased net losses of US$1.52 million. Despite ongoing losses, the company raised its full-year 2026 revenue outlook to at least US$279 million, leading to a 5.4% stock increase. This updated guidance reinforces the …

Did UBS’s Medtronic (MDT) Upgrade, After Strong Cardiac-Led Growth, Just Shift Its Investment Narrative?

Should Investors Buy Inogen as Low Valuation Meets Execution Risk?

Inogen, Inc. INGN trades at a steep sales-multiple discount even as second-quarter 2026 margins improved and international demand remained firm. The disconnect creates an interesting setup, but the operating recovery is not yet broad-based. Investors must weigh better cost control, expanding respiratory offerings and …

CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up

Cardinal Health, Inc. CAH reported fourth-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.91, beating the Zacks Consensus Estimate by 20.3%. The bottom line improved 40% year over year, aided by higher operating earnings, IEEPA tariff refunds, a lower tax rate and a …

Surging Earnings Estimates Signal Upside for Neogen (NEOG) Stock

CVRx Inc (CVRX) Stock News Today

Penumbra, Inc. (PEN) Stock Analysis: Evaluating the 11.45% Potential Upside in Medical Devices

Penumbra, Inc. (NYSE: PEN), a medical devices company with a $12.79 billion market cap, shows a potential upside of 11.45% based on analyst target prices. Despite a premium valuation with a forward P/E of 52.95, the company exhibits strong performance with 14.90% revenue growth …

Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists

Inogen, Inc. (INGN) has lowered its 2026 revenue outlook due to persistent U.S. channel pressure, despite experiencing better profitability and international growth in the second quarter. The company is facing a shift in the U.S. oxygen market towards portable oxygen concentrators as initial therapy, …

Bronstein, Gewirtz & Grossman LLC Urges iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against iTonic Holdings Ltd. (f/k/a Pheton Holdings Ltd.) and its officers, alleging violations of federal securities laws. The lawsuit claims that iTonic (NASDAQ: ITOC; previously PTHL) was involved in an alleged market manipulation …

Neuronetics Q2 Earnings Call Highlights

Key Points Interested in Neuronetics, Inc.? Here are five stocks we like better. Q2 results improved significantly: Revenue rose 9.1% year over year to $41.6 million, while the net loss narrowed to $3.4 million and adjusted EBITDA turned positive at $0.3 million. Greenbrook was …

Globus Medical (GMED) Upgraded to Strong Buy: Here's Why

Globus Medical (GMED) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The …

GLAUKOS Corp SEC Filing (Aug 11, 2026)

GLAUKOS Corp (GKOS) filed a Form 144 with the SEC on August 11, 2026, indicating a proposed sale of 60,000 shares of common stock acquired through a stock option exercise on the same date. The aggregate market value of these shares is $10,784,645.13, and …

GMED vs. ITGR: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Integer (ITGR). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Everyone has their own methods …

Stifel raises Alamar Biosciences stock price target on earnings beat

Stifel has increased its target price for ALAMAR BIOSCIENCES INC to $32 from $28. This update, reported by Reuters, reflects an analyst's revised valuation for the company. The article emphasizes that the content represents the author's opinion and should not be used as investment …

CVRx to replace CRO after cutting guidance and DOJ civil inquiry

CVRx announced it has let go of its Chief Revenue Officer Robert John and appointed Paul Verrastro as interim head of sales, following a disappointing earnings report and a disclosed Department of Justice civil investigation into its sales and marketing practices. The company also …

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 29, 2026 in iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. Lawsuit - ITOC

The Gross Law Firm is notifying shareholders of iTonic Holdings Ltd. (NASDAQ: ITOC) about a lead plaintiff deadline of September 29, 2026, in a class action lawsuit. The lawsuit alleges that during the class period from September 5, 2024, to July 29, 2025, the …

Portnoy Law Firm Announces Class Action on Behalf of Insulet Corporation Investors

The Portnoy Law Firm has announced a class action lawsuit on behalf of investors in Insulet Corporation (NASDAQ: PODD). The lawsuit alleges that Insulet made false and misleading statements regarding defective manufacturing controls and procedures, which led to multiple medical device corrections for its …

Viemed (VMD) Q2 2026 Earnings Call Transcript

Viemed Healthcare reported record Q2 2026 revenue of $78.1 million, a 24% year-over-year increase, driven by record ventilator patient counts and growth in sleep therapy and maternal health. The company also announced an all-time high of 12,635 active ventilator patients and significant expansion in …

Can Enovis (ENOV) Narrowing Losses Without Strong Sales Growth Sustain Its Long-Term Strategy?

Enovis Corporation (ENOV) reported Q2 2026 sales of US$582.78 million, a modest increase year-over-year, and significantly reduced its net loss to US$1.19 million from US$36.74 million. The company reaffirmed its 2026 revenue guidance of US$2.31 billion to US$2.37 billion, indicating management's confidence despite only …

Elutia Inc. (ELUT) stake of 2.19M shares reported by SilverArc

SilverArc Capital Management, LLC and Devesh Gandhi have reported a beneficial ownership of 2,192,980 shares of Elutia Inc. (ELUT) Class A common stock, representing a 4.9% stake. This information was disclosed in a SCHEDULE 13G SEC filing, indicating shared voting and dispositive power over …

UFP Technologies Executive Chairman Sold $5.00M In Company Stock

UFP Technologies Executive Chairman R. Jeffrey Bailly sold 15,695 shares of company stock for a total transaction value of $4,997,050. This insider transaction comes as UFPT shares are trading at $323.4, down 1.12%. The article also provides an overview of UFP Technologies's financial health, …

Haemonetics stock hits 52-week high at 88.73 USD

Haemonetics Corp's stock reached a new 52-week high of $88.73, marking a significant 67.34% increase over the past year and reflecting strong investor confidence. The medical technology company's market capitalization stands at $3.97 billion, with its P/E ratio of 42 suggesting it may be …

E. Ohman J or Asset Management AB Buys 119,605 Shares of Stryker Corporation $SYK

E. Ohman J or Asset Management AB significantly increased its stake in Stryker Corporation by 1,008% in the second quarter, acquiring 119,605 additional shares. This brings their total holding to 131,471 shares, valued at approximately $41.4 million. The medical technology company reported strong quarterly …

TELA BIO (TELA): SilverArc and Devesh Gandhi report 4.8% ownership stake

SilverArc Capital Management, LLC and Devesh Gandhi have jointly reported a beneficial ownership stake of 4.8% in TELA BIO, INC., comprising 2,137,201 shares of Class A Common Stock. They possess shared voting and dispositive power over all these shares, with neither holding sole authority. …

Varex Imaging (NASDAQ:VREX) Sees Strong Trading Volume After Strong Earnings

Earnings Flash (ALMR) Alamar Biosciences, Inc. Reports Q2 Revenue $29.4M, Vs. FactSet Est of $25.9M

Alamar Biosciences, Inc. (ALMR) announced its second-quarter revenue of $29.4 million, significantly exceeding the FactSet estimate of $25.9 million. This earnings flash highlights the company's financial performance for the recent quarter.

Tactile Systems Technology (NASDAQ:TCMD) Shares Gap Down Following Analyst Downgrade

Tactile Systems Technology (NASDAQ:TCMD) shares gapped down following an analyst downgrade by BTIG Research, which lowered its price target from $40 to $39 while maintaining a "Buy" rating. Despite the share price drop, the company reported strong Q2 2026 earnings, exceeding EPS and revenue …

Beta Bionics, Inc. Stock 12‑Month Price Target Raised to $20.31, Implies 24% Upside

Beta Bionics, Inc. (BBNX) has seen its average 12-month price target raised from $20.08 to $20.31 by 11 analysts, with forecasts ranging from $14 to $30.4 per share. This new target implies a potential upside of approximately 24% from its August 10 closing price. …

908 Devices Q2 2026 slides: 23% growth, profitability in sight

908 Devices Inc. reported a 23% year-over-year revenue growth in Q2 2026, exceeding Wall Street expectations, with revenue reaching $16.1 million. The company is nearing profitability, with management raising full-year 2026 revenue guidance to $68 million-$70 million and projecting positive adjusted EBITDA of $0.7 …